Correlation Between Adaptive Biotechnologies and MedinCell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and MedinCell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and MedinCell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptive Biotechnologies Corp and MedinCell SA, you can compare the effects of market volatilities on Adaptive Biotechnologies and MedinCell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of MedinCell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and MedinCell.

Diversification Opportunities for Adaptive Biotechnologies and MedinCell

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Adaptive and MedinCell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and MedinCell SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedinCell SA and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with MedinCell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedinCell SA has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and MedinCell go up and down completely randomly.

Pair Corralation between Adaptive Biotechnologies and MedinCell

If you would invest  490.00  in Adaptive Biotechnologies Corp on September 26, 2024 and sell it today you would earn a total of  149.00  from holding Adaptive Biotechnologies Corp or generate 30.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Adaptive Biotechnologies Corp  vs.  MedinCell SA

 Performance 
       Timeline  
Adaptive Biotechnologies 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.
MedinCell SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MedinCell SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, MedinCell is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Adaptive Biotechnologies and MedinCell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adaptive Biotechnologies and MedinCell

The main advantage of trading using opposite Adaptive Biotechnologies and MedinCell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, MedinCell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedinCell will offset losses from the drop in MedinCell's long position.
The idea behind Adaptive Biotechnologies Corp and MedinCell SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance